Public trust part of the life sciences supply chain mix

Complexities in the pharmaceutical, medical device, and biologics supply chain surpass any other industry, except nuclear power. Million-dollar pallets, toxic oncology meds, longer shipping channels—even the public trust, are part of the mix.

For the May/June print issue, Healthcare Packaging goes to Washington, Europe, and to a local FDA event, to take the pulse of the regulatory, compliance, processing, and packaging “links” in the life sciences supply chain.

Quality problems in successful batch production, continuing packaging materials challenges including developments in materials sciences to deal with leachables, extractables, delamination, elastomers—and even workforce development issues around the globe are impacting the drug supply chain. (Singapore is offering tax advantages for biologics manufacturers but needs to train regulatory officials to direct these efforts.)

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?